Misuse of soft mist inhalers (SMIs) is common among patients with chronic obstructive pulmonary disease (COPD), particularly those with low education levels, higher symptom scores, and a shorter ...
Chronic obstructive pulmonary disease (COPD), which includes emphysema and chronic bronchitis, affects more than 30 million Americans and is the fourth leading cause of death worldwide. Many people ...
Just 24.7% of elderly patients with chronic obstructive pulmonary disease (COPD) included in the study demonstrated correct usage of their inhaler. Despite all 200 patients included in the study being ...
Approximately two thirds of hospitalized adults with chronic obstructive pulmonary disease (COPD) received suboptimal treatment with inhalers, mainly resulting from errors, based on data from 96 ...
LOUISVILLE, Ky.--(BUSINESS WIRE)--A new study published in the Chronic Obstructive Pulmonary Diseases: Journal of the COPD Foundation shows how an innovative phone-based inhaler education program ...
Inhalers are the mainstay of treatment for asthma and chronic obstructive pulmonary disease (COPD). These products face limited generic competition in the US and remain expensive. To better understand ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results